Аssessment of disorders of statodynamic function due to oncological diseases of the brain in comparison with other locations of neoplasms in the medical and social system

Abstract

BACKGROUND: Studies have shown that, in 2019, malignant neoplasms were the major cause of adult disability in the Russian Federation. Thus, it is important to study functional disorders in this group of patients.

AIM: To conduct a comparative analysis of the degree of statodynamic impairment caused by malignancies, based on the location of the neoplasm, the tumor stage, and complications. Further, to justify the need for specialized diagnostic equipment for objectively analyzing the degree of statodynamic dysfunction.

MATERIALS AND METHODS: A prospective study was carried out on a group of disabled people aged 18 years and older, with malignant neoplasms (ICD code–10: C00–C97). These patients were initially recognized as disabled, and had further assessment of their degree of disability by the Bureau of Medical and Social Expertise of the Republic of Mordovia. The specialized diagnostic equipment used by the office for expert and rehabilitation diagnostics to assess impairment of statodynamic function was an ergometer with a diagnostic track and a power platform “ZEBRIS FDM-T, N/R COSMOS.” Indicators were analyzed using a software module which assess the degree of the musculoskeletal and nervous system dysfunction. We performed the collection and processing of data, and a comparative analysis. We also conducted an expert assessment of the dependence of the impairment of statodynamic functions on the main and concomitant diseases, and their complications.

RESULTS: The analysis of statodynamic functions in cancer patients showed that the patients with impaired statodynamics averaged 11.24% of the study population. The proportions according to tumor type were 72.4% for malignant neoplasms of bones and articular cartilage, to 5.06% for malignant neoplasms of the thyroid gland and pheochromocytoma. A high percentage of patients with impaired statodynamic function had malignancies of the brain, spinal cord and meninges (C70–C72), 41.7%. In cases of malignant neoplasms that were inaccurately designated, secondary, and were unspecified localizations or with metastases without an identified primary focus after radical treatment (C76–C80) the proportion was 40.0% relative to the group with these diagnoses. Due to complications of the underlying disease, pronounced and significantly pronounced impairment of statodynamic functions were found in the C70–C72 International Classification of Diseases, 10th revision (ICD-10) codes, which correspond to neoplasms of the brain, cerebellum, and spinal cord. Significantly expressed and moderate disorders were found in the C64–C68 ICD-10 codes, corresponding to malignant neoplasms of the kidney, renal pelvis, and bladder. Moderate and insignificant dysfunctions of statodynamics were detected in C50, malignant neoplasm of the mammary gland.

CONCLUSION: The chronic impairments of statodynamic function in cancer patients are most pronounced in cancers of bone and articular cartilage, and the brain and spinal cord. The prognosis of patients with malignant neoplasms depends on the stage of the disease, the site of the neoplasm, and the initial treatment. Relapses, tumor metastases, and complications of therapy play an important role in the functional disorders seen during follow up. High-tech diagnostic equipment such as “ZEBRIS FDM-T, H/R COSMOS” allows accurate clinical assessment of the functions associated with movement. This provides an objective basis for the clinical and expert classification of the severity of impaired statodynamic functions of the body.

Keywords

malignant neoplasms / statodynamic functions / statistics / medical and social expertise

References

[1] Sklyarenko RT, Dovgalyuk AZ, editors. Kliniko-ekspertnaya kharakteristika stoikikh narushenii funktsii pri novoobrazovaniyakh. Saint Petersburg: Herzen University; 2018. 472 p. (In Russ.).

[2] Клинико-экспертная характеристика стойких нарушений функций при новообразованиях : пособие для врачей / под ред. проф. Р.Т. Скляренко, проф. А.З. Довгалюк. СПб.: РГПУ им. А.И. Герцена, 2018. 472 с.

[3] Dymochka MA, Krasnovskaya ES, Verigina NB. Figures of disability among the adult population of the Russian Federation over 2017–2019 (information analysis product). Medical-Social Problems of Disability. 2020;(2):7–26. (In Russ.).

[4] Дымочка М.А., Красновская Е.С., Веригина Н.Б. Показатели инвалидности у взрослого населения российской федерации за период 2017–2019 гг. (информационно-аналитический материал) // Медико-социальные проблемы инвалидности. 2020. № 2. С. 7–26.

[5] Dmitriev VN, Andreeva NA, Urusova MA. Morbidity of the adult population of the Russian Federation to diseases classes in dynamics over 2010–2018. Medical-Social Problems of Disability. 2020;(2):27–32. (In Russ.).

[6] Дмитриев В.Н., Андреева Н.А., Урусова М.А. Заболеваемость взрослого населения Российской Федерации по классам болезней в динамике за 2010–2018 гг. // Медико-социальные проблемы инвалидности. 2020. № 2. С. 27–32.

[7] Pilnik IA, Luzina IM. Analysis of the forming of primary disability due to malignant neoplasms in the adult population of the Chelyabinsk region in dynamics for 2014–2018. Medical-Social Problems of Disability. 2020;(2):39–45. (In Russ.).

[8] Пильник И.А., Лузина И.М. Анализ формирования первичной инвалидности вследствие злокачественных новообразований у взрослого населения Челябинской области в динамике за 2014–2018 гг. // Медико-социальные проблемы инвалидности. 2020. № 2. С. 39–45.

[9] Laushkina LS, Shirobokova SV, Titova SA, Pasechnaya IV. Procedure for carrying out medical-social expertise during the spread of a new coronavirus infection COVID-19. Medical-Social Problems of Disability. 2020;(2):89–96. (In Russ.).

[10] Лаушкина Л.С., Широбокова С.В., Титова С.А., Пасечная И.В. Порядок проведения медико-социальной экспертизы в период распространения новой коронавирусной инфекции COVID-19 // Медико-социальные проблемы инвалидности. 2020. № 2. С. 89–96.

[11] Naumenko LL, Kozlov SI, Shahsuvaryan SB, et al. Metastases of malignant tumors without an unknown primary site. Medical-Social Problems of Disability. 2020; (4):39–47. (In Russ.).

[12] Науменко Л.Л., Козлов С.И., Шахсуварян С.Б., и др. Метастазы злокачественных опухолей без выявленного первичного очага // Медико-социальные проблемы инвалидности. 2020. № 4. С. 39–47.

[13] Pomnikov VG, Penina GO, editors. Sto let mediko-sotsial’noi ekspertizy. Aktual’nye problemy i reabilitatsiya. Saint Petersburg: Aising; 2018. 288 p. (In Russ.).

[14] Сто лет медико-социальной экспертизы. Актуальные проблемы и реабилитация : cборник трудов / под ред. В.Г. Помникова, Г.О. Пениной. СПб.: Айсинг, 2018. 288 с.

[15] Kukina GN, Podsevatkin VG, Kiryukhina SV. Link between metabolic syndrome and obesity in adolescents. Collection of articles based on the materials of the international scientific-practical conference “Sovremennaya meditsina novye podkhody i aktual’nye issledovaniya”. 2020 Oct 22; Groznyi. Groznyi; 2020. P. 99–103. (In Russ.).

[16] Кукина Г.Н., Подсеваткин В.Г., Кирюхина С.В. Связь метаболического синдрома и ожирения у подростков // Сборник статей по материалам международной научно-практической конференции «Современная медицина новые подходы и актуальные исследования». Грозный, 22 октября 2020 г. Грозный, 2020. С. 99–103.

[17] Kukina GN, Kiryukhina SV, Labunsky DA, et al. Examining dynamic changes in the complement system components and immune complexes of various fractions in adolescents with obesity and metabolic syndrome affected by antihypoxants. Russian Journal of Immunology. 2020;23(4):479–486. (In Russ.). doi: 10.46235/1028-7221-434-EDC

[18] Кукина Г.Н., Кирюхина С.В., Лабунский Д.А., и др. Изучение динамики компонентов системы комплемента и иммунных комплексов различных фракций у подростков с ожирением и метаболическим синдромом под влиянием антигипоксантов // Российский иммунологический журнал. 2020. Т. 23, №4. С. 479–486. doi: 10.46235/1028-7221-434-EDC

[19] Labunskiy D, Kiryukhina S, Podsevatkin V. Comparison of experimental cellular and molecular therapy in motor neuron disease. Eur J Neurol. 2019;26(1):829.

[20] Labunskiy D., Kiryukhina S., Podsevatkin V. Comparison of experimental cellular and molecular therapy in motor neuron disease // Eur J Neurol. 2019. Vol. 26, Suppl 1. P. 829.

[21] Labunskiy D, Kiryukhina S, Podsevatkin V. Hyperbaric oxygenation in treatment of tourette of disease in comparison with medication therapy and their influence of immunity parameters. Eur J Neurol. 2019;26(1):949.

[22] Labunskiy D., Kiryukhina S., Podsevatkin V. Hyperbaric oxygenation in treatment of tourette of disease in comparison with medication therapy and their influence of immunity parameters. Eur J Neurol. 2019. Vol. 26, Suppl 1. P. 949.

[23] WHO; EASO. European Association for the Study of Obesity and World Obesity Federation statement on the state of health in the WHO European Region, including lessons learned from the COVID-19 pandemic. Available from: https://www.euro.who.int/__data/assets/pdf_file/0007/462508/ai2EASO.pdf. Accessed: August 3, 2022.

[24] WHO; EASO. European Association for the Study of Obesity and World Obesity Federation statement on the state of health in the WHO European Region, including lessons learned from the COVID-19 pandemic. Режим доступа: https://www.euro.who.int/__data/assets/pdf_file/0007/462508/ai2EASO.pdf. Accessed: August 3, 2022.

[25] Labunskiy D, Kiryukhina S, Kolmykova N. First scientific description of the hepatolenticular degeneration. Abstracts of the MDS Virtual Congress; September 2020. Р. 231. Available from: https://www.mdscongress.org/Congress-Branded/Congress-2020-Files/MDSVirtualCongressBasicScienceAbstracts.pdf. Accessed: August 3, 2022.

[26] Labunskiy D., Kiryukhina S., Kolmykova N. First scientific description of the hepatolenticular degeneration // Abstracts of the MDS Virtual Congress; September 2020. Р. 231. Available at: https://www.mdscongress.org/Congress-Branded/Congress-2020-Files/MDSVirtualCongressBasicScienceAbstracts.pdf. Accessed: August 3, 2022.

[27] Labunskiy D, Yurasova E, Kurgaev N, et al. Endocrine predicts of the formation of complex motor tics in tourette’s disease. Abstracts of the MDS Virtual Congress; September 2020. Р. 1456. Available from: https://www.mdscongress.org/Congress-Branded/Congress-2020-Files/MDSVirtualCongressBasicScienceAbstracts.pdf. Accessed: August 3, 2022.

[28] Labunskiy D., Yurasova E., Kurgaev N., et al. Endocrine predicts of the formation of complex motor tics in tourette’s disease // Abstracts of the MDS Virtual Congress; September 2020. Р. 1456. Режим доступа: https://www.mdscongress.org/Congress-Branded/Congress-2020-Files/MDSVirtualCongressBasicScienceAbstracts.pdf. Accessed: August 3, 2022.

[29] Labunskiy D, Kiryukhina S, Podsevatkin V. Cytokines and brain specific antibodies in experimental cellular and molecular treatment of huntington’s diseases. Abstracts of the MDS Virtual Congress; September 2020. Р. 253. Available from: https://www.mdscongress.org/Congress-Branded/Congress-2020-Files/MDSVirtualCongress-BasicScienceAbstracts.pdf. Accessed: August 3, 2022.

[30] Labunskiy D., Kiryukhina S., Podsevatkin V. Cytokines and brain specific antibodies in experimental cellular and molecular treatment of huntington’s diseases // Abstracts of the MDS Virtual Congress; September 2020. Р. 253. Режим доступа: https://www.mdscongress.org/Congress-Branded/Congress-2020-Files/MDSVirtualCongressBasicScienceAbstracts.pdf. Accessed: August 3, 2022.

RIGHTS & PERMISSIONS

Eco-Vector